High prevalence of dyslipidemia and associated risk factors among rural Chinese adults

[1] Murray CJ(1997)Mortality by cause for eight regions of the world: global burden of disease study Lancet 349 1269-1276

[2] Lopez AD(2003)Global health improvement and WHO: shaping the future Lancet 362 2083-2088

[3] Jong-wook L(1998)Emerging epidemic of cardiovascular disease in developing countries Circulation 97 596-601

[4] Reddy KS(2001)Sino-MONICA project: a collaborative study on trends and determinants in cardiovascular diseases in china, part i: morbidity and mortality monitoring Circulation 103 462-468

[5] Yusuf S(2000)Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity JAMA 284 311-318

[6] Wu Z(2001)Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization Circulation 104 2746-2753

[7] Yao C(2002)MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 7-22

[8] Zhao D(2005)Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 1267-1278

[9] Wu G(2004)Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines J Am Coll Cardiol 44 720-732

[10] Wang W(2012)Prevalence of lipid abnormalities in the United States: the national health and nutrition examination survey 2003-2006 J Clin Lipidol 6 325-330

[1] Murray CJ(1997)Mortality by cause for eight regions of the world: global burden of disease study Lancet 349 1269-1276

[2] Lopez AD(2003)Global health improvement and WHO: shaping the future Lancet 362 2083-2088

[3] Jong-wook L(1998)Emerging epidemic of cardiovascular disease in developing countries Circulation 97 596-601

[4] Reddy KS(2001)Sino-MONICA project: a collaborative study on trends and determinants in cardiovascular diseases in china, part i: morbidity and mortality monitoring Circulation 103 462-468

[5] Yusuf S(2000)Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity JAMA 284 311-318

[6] Wu Z(2001)Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization Circulation 104 2746-2753

[7] Yao C(2002)MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 7-22

[8] Zhao D(2005)Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 1267-1278

[9] Wu G(2004)Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines J Am Coll Cardiol 44 720-732

[10] Wang W(2012)Prevalence of lipid abnormalities in the United States: the national health and nutrition examination survey 2003-2006 J Clin Lipidol 6 325-330